Can chatting with others and AI help breast cancer patients feel less anxious?
NCT ID NCT06604078
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study from the University of Central Florida involved 199 adults who had breast cancer imaging. Researchers created a social platform called MammoChat where patients could share their experiences anonymously. They also collected de-identified images to train AI models for better detection. The goal was to understand if social support and AI could reduce anxiety and improve outcomes in breast cancer screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could point toward a supportive online tool that helps patients feel less anxious during breast cancer screening and aids in developing AI for earlier detection.
What could go wrong
This was a small, completed study focused on building a platform and collecting data, not testing a treatment. The AI models and social network effects need much larger validation before any real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Central Florida
Orlando, Florida, 32827, United States